LINDSAY HOWARD: Open Payments
NPI 1720289135 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,015 in 66 payments from 16 companies in 2025. Trend: 2023 $1,323 · 2024 $1,125 · 2025 $1,015
Food & beverage: $1,015
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $214 |
| AstraZeneca Pharmaceuticals LP | 11 | $210 |
| Lilly USA, LLC | 14 | $144 |
| Novo Nordisk Inc | 4 | $80 |
| Abbott Laboratories | 5 | $80 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Exact Sciences Corporation | 2 | $35 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Seqirus USA Inc | 1 | $18 |
Products named: MOUNJARO, VRAYLAR, FARXIGA, AIRSUPRA, FREESTYLE LIBRE 3, SHINGRIX, UBRELVY, QULIPTA.
Industry payments across SC — which companies pay providers there.
